Biotech stock pick = CHTP:NASDAQ Followed this company for a long time
CHTP
Parkinsons treatment drug
sold in Japan and elsewhere for 20 YEARS already with no problems
my guess FDA mafia kept them out of the USA to protect big pharma competitor with patent treatment monopoly.
now FDA approval very very close.
60M shares out but 40% institutional owned , 20% management owned
6M shares short -squeeze potential
float very tight -
up 20% today, but this is just the start
traded north of $8 last time they tried for FDA approval
now patent for competitor expired, no reason for FDA to block this -- vote was 7-4 against last time round only need 1 more or two more votes to get approval
market sales projected at $300 M == $15 share price